|
5-Heptenoic acid,7-(3-hydroxy-5-oxo-1-cyclopenten-1-yl)-,methyl ester,[R-(Z)]-
|
|
42541-96-8
|
|
5-Heptenoic acid,7-[5-oxo-3-[(triethylsilyl)oxy]-1-cyclopenten-1-yl]-,methyl ester,(5Z)-
|
|
102494-28-0
|
|
Bicyclo[3.2.0]hept-2-en-6-one, (1R,5S)-
|
|
71155-05-0
|
|
Bicyclo[3.2.0]hept-2-en-6-one, (1S,5R)-
|
|
71155-04-9
|
|
Carbamic acid, N-[(7S)-5-(phenylmethyl)-5-azaspiro[2.4]hept-7-yl]-, 1,1-dimethylethyl ester
|
|
144282-37-1
|
|
N-Succinimidyl-N-Methylcarbamate
|
|
18342-66-0
|
|
5-Bromophthalide
|
|
64169-34-2
|
|
I-Indanone
|
|
83-33-0
|
|
N-(2-Bromobenzyloxy Carbonyloxy) Succinimide
|
|
128611-93-8
|
|
endo-N-Hydroxy-5-norbornene-2,3-dicarboximide
|
|
21715-90-2
|
|
Gemeprost
|
|
64318-79-2
|
|
N-(Benzyloxy Carbonyloxy) Succinimide
|
|
13139-17-8
|
|
N-(2-Chlorobenzyloxy Carbonyloxy) Succinimide
|
|
65853-65-8
|
|
Iodoacetonitrile
|
|
624-75-9
|
|
Imidazo[5,1-c][1,2,4]triazine-8-carboxamide,1,4-dihydro-3-nitro-4-oxo-
|
|
287964-59-4
|
|
DIETHYLPHOSPHONOACETIC ACID
|
|
3095-95-2
|
|
Tafluprost acid
|
|
209860-88-8
|
|
Cyclopentanol, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2-methylene-, (1R,3R,4S)-
|
|
701278-56-0
|
|
Cyclopropanamine, 2-fluoro-, (1R,2S)-, 4-methylbenzenesulfonate (1:1)
|
|
143062-84-4
|
|
4-Pentyn-1-ol
|
|
5390-04-5
|
|
Olmesartan
|
|
144689-24-7
|
|
N-(tert-Butoxycarbonyl)-1,3-phenylenediaMine
|
|
68621-88-5
|
|
N-(2-Oxoethyl)phthalimide
|
|
2913-97-5
|
|
Morpholine hydrochloride
|
|
10024-89-2
|
|
α-D-Ribofuranose, 1,3,5-tribenzoate
|
|
22224-41-5
|
|
Cyclopentaneheptanoic acid, 5-(acetyloxy)-2-(hydroxymethyl)-3-[(tetrahydro-2H-pyran-2-yl)oxy]-, methyl ester, (1R,2S,3R,5S)-
|
|
61302-47-4
|
|
[1,1'-Biphenyl]-4-carboxylic acid, (3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-1-octen-1-yl]-2H
|
|
31753-00-1
|
|
[1,1'-Biphenyl]-4-carboxylic acid, (3aR,4R,5R,6aS)-4-[(1E,3S)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5-phenyl-1-penten-1-yl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl ester
|
|
865087-09-8
|
|
[1,1'-Biphenyl]-4-carboxylic acid, 4-[3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-octenyl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl ester, [3aR-[3a,4(1E,3S*),5,6a]]-
|
|
137624-47-6
|
|
[1,1'-Biphenyl]-4-carboxylic acid, (3aR,4R,5R,6aS)-hexahydro-4-[(1E,3S)-3-hydroxy-1-octen-1-yl]-2-oxo-2H-cyclopenta[b]furan-5-yl ester
|
|
51014-26-7
|
|
[1,1'-Biphenyl]-4-carboxylic acid, (3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-yl ester
|
|
54142-64-2
|
|
α-oxo-4-phenylbutanoic Acid
|
|
710-11-2
|
|
Sodium faropenem
|
|
122547-49-3
|
|
t-butoxycarbonylmethyltriphenylphosphoniumbromide
|
|
59159-39-6
|
|
Trityl olmesartan acid
|
|
752179-89-8
|
|
Phthalimidopropionaldehyde
|
|
2436-29-5
|
|
Triphenyl borane-sodium hydroxide adduct
|
|
12113-07-4
|
|
P-Tolylsulfoxide
|
|
1774-35-2
|
|
Trimethyl Phosphonoacetate
|
|
5927-18-4
|
|
Sodium Phenylpyruvate Monohydrate
|
|
122049-54-1
|
|
Phosphonitrile fluoride trimer
|
|
15599-91-4
|
|
α-Bromo-o-chloro acetophenone
|
|
5000-66-8
|
|
[1,1'-Biphenyl]-4-carboxylic acid,(3aR,4R,5R,6aS)-4-[(1E,3R)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl ester
|
|
865087-08-7
|
|
[1,1'-Biphenyl]-4-carboxylic acid, 4-[4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl ester, [3aR-[3a,4(1E,3R*),5,6a]]-
|
|
54713-44-9
|
|
[1,1'-Biphenyl]-4-carboxylic acid, hexahydro-2-oxo-4-[(phenylmethoxy)methyl]-2H-cyclopenta[b]furan-5-yl ester, (3a,4,5,6a)-(-)-
|
|
31752-98-4
|
|
15S-5,6-trans-Latanprost
|
|
1235141-39-5
|
|
Olmesartan medoxomil impurity V
|
|
157356-74-6
|
|
Diphenylethoxy Phosphine (Ethyl diphenyl phosphinite)
|
|
719-80-2
|
|
1,2,4-Butanetriol
|
|
3068-00-6
|
|
Phenylpyruvic Acid
|
|
156-06-9
|
|
Gadoteric acid
|
|
72573-82-1
|
|
Methyl 4-hydroxyphenylacetate
|
|
14199-15-6
|
|
Hydrindantin
|
|
5103-42-4
|
|
Lithium acetoacetate
|
|
3483-11-2
|
|
Peramivir Trihydrate
|
|
1041434-82-5
|
|
Olmesartan medoxomil
|
|
144689-63-4
|
|
Eldecalcitol
|
|
104121-92-8
|
|
ethynyltoluene
|
|
766-97-2
|
|
Diphenylphoshinic chloride
|
|
1499-21-4
|
|
α-D-Arabinofuranose, 2-deoxy-2-fluoro-, 1,3,5-tribenzoate
|
|
97614-43-2
|
|
Limaprost
|
|
74397-12-9
|
|
Phenylpyruvic acid, sodium salt monohydrate
|
|
114-76-1
|
|
Hydroxyphenethyl alcohol
|
|
501-94-0
|
|
15-keto-Bimatoprost
|
|
1163135-96-3
|
|
[1,1'-Biphenyl]-4-carboxylic acid,4-(4,4-difluoro-3-oxo-1-octenyl)hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl ester,[3aR-[3a,4(E),5,6a]]-
|
|
118583-35-0
|
|
[1,1'-Biphenyl]-4-carboxylic acid,(3aR,4R,5R,6aS)-hexahydro-4-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-2-oxo-2H-cyclopenta[b]furan-5-yl ester
|
|
41639-73-0
|
|
[1,1'-Biphenyl]-4-carboxylic acid,(3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-5-phenyl-1-penten-1-yl]-2H-cyclopenta[b]furan-5-yl ester
|
|
41639-72-9
|
|
[1,1'-Biphenyl]-4-carboxylic acid, hexahydro-2-oxo-4-(3-oxodecyl)-2H-cyclopenta[b]furan-5-yl ester, [3aR-(3a,4,5,6a)]-
|
|
120373-45-7
|
|
[1,1'-Biphenyl]-4-carboxylic acid, 4-[4-(3-chlorophenoxy)-3-oxo-1-butenyl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl ester, [3aR-[3a,4(E),5,6a]]-
|
|
54324-79-7
|
|
[1,1'-Biphenyl]-4-carboxylic acid, hexahydro-4-(3-hydroxy-3-methyl-1-octenyl)-2-oxo-2H-cyclopenta[b]furan-5-ester, [3aR-[3a,4(1E,3S*),5,6a]]-
|
|
42743-23-7
|
|
15-keto-Travoprost
|
|
404830-45-1
|
|
15R-Bimatoprost
|
|
1163135-92-9
|
|
15S-Travoprost
|
|
340181-93-3
|
|
Origanum oil
|
|
8007-11-2
|
|
15S-Latanoprost
|
|
145773-22-4
|
|
Ipriflavone
|
|
35212-22-7
|
|
Olmesartan medoxomil impurity II
|
|
896419-17-3
|
|
Olmesartan intermediate impurity IV
|
|
1092980-84-1
|
|
15S-Cloprostenol
|
|
54276-22-1
|
|
1-Cyclopentene-1-heptanoic acid, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5-oxo-, methyl ester
|
|
161978-56-9
|
|
Olmesartan medoxomil impurity I
|
|
879562-26-2
|
|
1-(4-Chlorophenyl)ethanol
|
|
3391-10-4
|
|
3-(2-Methyl-1H-imidazol-1-yl)propanenitrile
|
|
23996-55-6
|
|
Butenafine hydrochloride
|
|
101827-46-7
|
|
Ozagrel
|
|
82571-53-7
|
|
Cholesteryl benzoate
|
|
604-32-0
|
|
Nimorazole
|
|
6506-37-2
|
|
2-Nitrophenoxyacetic acid
|
|
1878-87-1
|
|
3-(4-Fluorophenoxy)propionic acid
|
|
1579-78-8
|
|
Isoconazole nitrate
|
|
24168-96-5
|
|
2-Phenoxybutyric acid
|
|
13794-14-4
|
|
Ethoxyquin
|
|
91-53-2
|
|
2-Phenoxypropionic acid
|
|
940-31-8
|
|
Olmesartan intermediate impurity VI
|
|
157356-73-5
|
|
Olmesartan intermediate impurity V
|
|
172875-53-5
|
|
Olmesartan medoxomil impurity IV
|
|
1040250-19-8
|
|
1-Allylimidazole
|
|
31410-01-2
|
|
Allicin
|
|
539-86-6
|
|
Olmesartan intermediate impurity II
|
|
144690-07-3
|
|
1-(2-Chlorophenyl)-1-ethanol
|
|
13524-04-4
|